| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Stephanie Lin, Pradeep Ramulu, Ecosse L Lamoureux, Charumathi Sabanayaga. Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review. Clinical & experimental ophthalmology. vol 44. issue 4. 2017-02-28. PMID:26991970. |
in recent years, the successful implementation of public health programs in developed countries has been thought to contribute to decreases in blindness from dr. |
2017-02-28 |
2023-08-13 |
Not clear |
| Francesco Saverio Sorrentino, Michael Allkabes, Giulia Salsini, Claudio Bonifazzi, Paolo Perr. The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy. Life sciences. vol 162. 2017-02-17. PMID:27497914. |
diabetic retinopathy (dr) is a remarkable microvascular complication of diabetes and it has been considered the leading cause of legal blindness in working-age adults in the world. |
2017-02-17 |
2023-08-13 |
Not clear |
| Bo Qin, Jinwen Liu, Shenwen Liu, Baijun Li, Jing Re. MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy. Acta biochimica et biophysica Sinica. vol 48. issue 8. 2017-02-13. PMID:27421659. |
diabetic retinopathy (dr) is the leading cause of new-onset blindness. |
2017-02-13 |
2023-08-13 |
human |
| Cherie Fathy, Shriji Patel, Paul Sternberg, Sahar Kohani. Disparities in Adherence to Screening Guidelines for Diabetic Retinopathy in the United States: A Comprehensive Review and Guide for Future Directions. Seminars in ophthalmology. vol 31. issue 4. 2017-02-08. PMID:27116205. |
diabetic retinopathy (dr) is the leading cause of new-onset blindness in american adults aged 20-74 years old. |
2017-02-08 |
2023-08-13 |
Not clear |
| L Zhang, Z K Zhang, S Lian. Epigallocatechin-3-gallate protects retinal vascular endothelial cells from high glucose stress in vitro via the MAPK/ERK-VEGF pathway. Genetics and molecular research : GMR. vol 15. issue 2. 2017-02-08. PMID:27323164. |
diabetic retinopathy (dr) is a frequent microvascular complication of diabetes, and one of the most common causes of legal blindness in the world. |
2017-02-08 |
2023-08-13 |
human |
| M Zhao, C H Li, Y L Li. Toll-like receptor (TLR)-2/4 expression in retinal ganglion cells in a high-glucose environment and its implications. Genetics and molecular research : GMR. vol 15. issue 2. 2017-02-01. PMID:27173229. |
diabetic retinopathy (dr), a major complication of diabetes mellitus, is the leading cause of adult blindness. |
2017-02-01 |
2023-08-13 |
Not clear |
| Pablo Zoroquiain, Natalia Vila, Vasco Bravo-Filho, Ana Beatriz T Dias, Debra M Sanft, John Chen, John Galic, Michael Kapusta, Christina Mastromonaco, Sultan S Aldrees, Julia Burnier, Miguel N Burnie. Pericyte Status in Routinely Discarded Vitrectomy Samples May Be an Early Marker of Diabetic Retinopathy. Ophthalmic research. vol 56. issue 2. 2017-01-31. PMID:27160208. |
diabetic retinopathy (dr) is the leading cause of blindness among the working-age population. |
2017-01-31 |
2023-08-13 |
Not clear |
| J E Muñoz de Escalona-Rojas, A Quereda-Castañeda, O García-Garcí. [Update of diabetic retinopathy for Primary Care physicians: Towards an improvement of telematic medicine]. Semergen. vol 42. issue 3. 2017-01-30. PMID:26239670. |
diabetic retinopathy (dr) is considered the most common cause of blindness in the working-age population in industrialised countries, with diabetic macular oedema being the most common reason of decreased visual acuity in diabetics. |
2017-01-30 |
2023-08-13 |
Not clear |
| Michelino Di Rosa, Gisella Distefano, Caterina Gagliano, Dario Rusciano, Lucia Malaguarner. Autophagy in Diabetic Retinopathy. Current neuropharmacology. vol 14. issue 8. 2017-01-17. PMID:26997506. |
diabetic retinopathy (dr) is a serious microvascular complication of diabetes and accounts for 5% of all blindness. |
2017-01-17 |
2023-08-13 |
Not clear |
| Małgorzata Mrugacz, Anna Bryl, Artur Bossowsk. Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients. Current neuropharmacology. vol 14. issue 8. 2017-01-17. PMID:27212050. |
diabetic retinopathy (dr) is an important complication of diabetes and is considered one of the main causes of blindness in moderate-income and highly-developed countries. |
2017-01-17 |
2023-08-13 |
Not clear |
| Joos Meyer, Karim Johnson, Joshua Bowyer, Josephine Muir, Angus Turne. Evaluating a health video on diabetic retinopathy. Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals. vol 27. issue 1. 2017-01-13. PMID:26855009. |
blindness can be prevented in 98% of cases if dr is identified and treated early. |
2017-01-13 |
2023-08-13 |
human |
| Joanna Kur, Michael A Burian, Eric A Newma. Light adaptation does not prevent early retinal abnormalities in diabetic rats. Scientific reports. vol 6. 2017-01-09. PMID:26852722. |
the aetiology of diabetic retinopathy (dr), the leading cause of blindness in the developed world, remains controversial. |
2017-01-09 |
2023-08-13 |
rat |
| Chee Wai Wong, Ecosse L Lamoureux, Ching-Yu Cheng, Gemmy Chui Ming Cheung, E Shyong Tai, Tien Y Wong, Charumathi Sabanayaga. Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study. EBioMedicine. vol 5. 2016-12-30. PMID:27077127. |
chronic kidney disease (ckd) has been shown to be associated with diabetic retinopathy (dr) and age-related macular degeneration (amd), leading causes of blindness in elderly adults in previous studies. |
2016-12-30 |
2023-08-13 |
Not clear |
| Carmen Valverde, Maria Garcia, Roberto Hornero, Maria I Lopez-Galve. Automated detection of diabetic retinopathy in retinal images. Indian journal of ophthalmology. vol 64. issue 1. 2016-12-20. PMID:26953020. |
diabetic retinopathy (dr) is a disease with an increasing prevalence and the main cause of blindness among working-age population. |
2016-12-20 |
2023-08-13 |
Not clear |
| G V S Murthy, Taraprasad Da. Diabetic care initiatives to prevent blindness from diabetic retinopathy in India. Indian journal of ophthalmology. vol 64. issue 1. 2016-12-20. PMID:26953024. |
the present review highlights the observation that the risk factors for dr need an integrated diabetic care pathway where the eye care team has to work in close collaboration and partnership with a diabetic care team has to reduce the risk of blindness from dr. |
2016-12-20 |
2023-08-13 |
Not clear |
| Rajiv Raman, Laxmi Gella, Sangeetha Srinivasan, Tarun Sharm. Diabetic retinopathy: An epidemic at home and around the world. Indian journal of ophthalmology. vol 64. issue 1. 2016-12-20. PMID:26953027. |
prevention of blindness due to diabetic retinopathy (dr) requires effective screening strategies, for which eye care providers need to know the magnitude of the burden and the risk factors pertinent in their geographical location. |
2016-12-20 |
2023-08-13 |
Not clear |
| Saad Hajar, Ali Al Hazmi, Mustafa Wasli, Ahmed Mousa, Mansour Rabi. Prevalence and causes of blindness and diabetic retinopathy in Southern Saudi Arabia. Saudi medical journal. vol 36. issue 4. 2016-12-13. PMID:25828282. |
to determine the prevalence and causes of blindness and diabetic retinopathy (dr) in jazan district, southern saudi arabia. |
2016-12-13 |
2023-08-13 |
Not clear |
| Stefano Fogli, Selene Mogavero, Colin Gerard Egan, Marzia Del Re, Romano Danes. Pathophysiology and pharmacological targets of VEGF in diabetic macular edema. Pharmacological research. vol 103. 2016-12-13. PMID:26607863. |
diabetic macular edema (dme) is a serious condition that can cause blindness in diabetic patients suffering from diabetic retinopathy (dr). |
2016-12-13 |
2023-08-13 |
Not clear |
| J Morgan Micheletti, Andrew M Hendrick, Farah N Khan, David C Ziemer, Francisco J Pasque. Current and Next Generation Portable Screening Devices for Diabetic Retinopathy. Journal of diabetes science and technology. vol 10. issue 2. 2016-12-13. PMID:26888973. |
diabetic retinopathy (dr) is the leading cause of legal blindness in the united states, and with the growing epidemic of diabetes, a global increase in the incidence of dr is inevitable, so it is of utmost importance to identify the most cost-effective tools for dr screening. |
2016-12-13 |
2023-08-13 |
Not clear |
| Nicola M Glasson, Lisa J Crossland, Sarah L Larkin. An Innovative Australian Outreach Model of Diabetic Retinopathy Screening in Remote Communities. Journal of diabetes research. vol 2016. 2016-10-25. PMID:26798648. |
this innovative model has greatly improved accessibility to dr screening in remote communities, thereby reducing preventable blindness. |
2016-10-25 |
2023-08-13 |
Not clear |